A novel, bio-reducible gene vector containing arginine and histidine enhances gene transfection and expression of plasmid DNA

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 2, 2011, Pages 202-207

  Tanaka, Ko ^a   Kanazawa, Takanori ^a   Ogawa, Takaya ^a   Suda, Yumiko ^a   Takashima, Yuuki ^a   Fukuda, Tsunehiko ^b   Okada, Hiroaki ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Disulfide cross linkage; Endosomal escape; Peptide gene vector

Indexed keywords

ARGININE; CHLOROQUINE; CYSTEINE; HISTIDINE; LIPOFECTAMINE; PLASMID DNA;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; DISULFIDE BOND; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; PINOCYTOSIS;

ANIMALS; ARGININE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, COMPLEMENTARY; GENETIC VECTORS; HISTIDINE; PLASMIDS; TRANSFECTION; UP-REGULATION;

EID: 79551488608     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.202     Document Type: Article

References (26)

1. Orlacchio A., Bernardi G., Orlacchio A., Martino S., Mini Rev. Med. Chem., 7, 1166-1176 (2007).
2. Pappas T. C., Bader A. G., Andruss B. F., Brown D., Ford L. P., Expert. Opin. Ther. Targets, 12, 115-127 (2008).
3. López-Fraga M., Wright N., Jiménez A., Infect. Disord. Drug Targets, 8, 262-273 (2008).
4. Dykxhoorn D. M., Expert. Opin. Ther. Pat., 19, 475-491 (2009).
5. Ponnappa, B. C., Curr. Opin. Investig. Drugs, 10, 418-424 (2009).
6. D'Costa J., Mansfield S. G., Humeau L. M., Curr. Opin. Mol. Ther., 11, 554-564 (2009).
7. Kesisoglou F., Schmiedlin-Ren P., Fleisher D., Zimmermann E. M., Mol. Pharm., 7, 619-629 (2010).
8. Björklund T., Carlsson T., Cederfjäll E. A., Carta M., Kirik D., Brain, 133, 496-511 (2010).
9. Ramsay E., Hadgraft J., Birchall J., Gumbleton M., Int. J. Pharm., 210, 97-107 (2000).
10. Ferrari M. E., Nguyen C. M., Zelphati O., Tsai Y., Felgner P. L., Hum. Gene Ther., 10, 341-351 (1998).
11. Kogure K., Akita H., Harashima H., J. Controlled Release, 122, 246-251 (2007).
12. Nori A., Jensen K. D., Tijerina M., Kopecková P., Kopecek J., Bioconjug. Chem., 14, 44-50 (2003).
13. Lee J., Jung E., Park J., Park D., Biotechnol. Appl. Biochem., 42, 169-173 (2005).
14. Wender P. A., Mitchell D. J., Pattabiraman K., Pelkey E. T., Steinman L., Rothbard J. B., Proc. Natl. Acad. Sci. U.S.A., 97, 13003-13008 (2000).
15. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y., J. Biol. Chem., 276, 5836-5840 (2001).
16. Goun E. A., Pillow T. H., Jones L. R., Rothbard J. B., Wender P. A., Chembiochem., 7, 1497-1515 (2006).
17. Futaki S., Nakase I., Tadokoro A., Takeuchi T., Jones A. T., Biochem. Soc. Trans., 35, 784-787 (2007).
18. Khalil I. A., Kogure K., Futaki S., Harashima H., J. Biol. Chem., 281, 3544-3551 (2006).
19. Sethuraman V. A., Bae Y. H., J. Controlled Release, 118, 216-224 (2007).
20. Kleemann E., Jekel N., Dailey L. A., Roesler S., Fink L., Weissmann N., Schermuly R., Gessler T., Schmehl T., Roberts C. J., Seeger W., Kissel T., J. Drug Target, 17, 638-651 (2009).
21. Tanaka K., Kanazawa T., Ogawa T., Takashima Y., Fukuda T., Okada H., Int. J. Pharm., 398, 219-224 (2010).
22. Damen M., Aarbiou J., van Dongen S. F., Buijs-Offerman R. M., Spijkers P. P., van Zden Heuvel M., Kvashnina K., Nolte R. J., Scholte B. J., Feiters M. C., J. Controlled Release, 145, 33-39 (2010).
23. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., Harashima H., Sugiura Y., Bioconjug. Chem., 12, 1005-1011 (2001).
24. Wolfert M. A., Seymour L. W., Gene Ther., 5, 409-411 (1998).
25. Khalil I. A., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., Harashima H., Gene Ther., 11, 636-644 (2004).
26. Kogure K., Akita H., Yamada Y., Harashima H., Adv. Drug Deliv. Rev., 60, 559-571 (2008).